Ulrike Naumann

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Topics

Endoplasmic Reticulum Stress

Tyrosine Kinase

Top Venues

Molecular oncology

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Leonie Schumacher, Rédouane Slimani, Laimdota Zizmare, Jakob Ehlers, Felix Kleine Borgmann, Julia C Fitzgerald, Petra Fallier-Becker, Anja Beckmann, Alexander Grißmer, Carola Meier, Ali El-Ayoubi, Kavi Devraj, Michel Mittelbronn, Christoph Trautwein, Ulrike Naumann
TGF-Beta Modulates the Integrity of the Blood Brain Barrier In Vitro, and Is Associated with Metabolic Alterations in Pericytes. Biomedicines 11 (1) (2023)
Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Irene Gonzalez-Menendez, Leticia Quintanilla Fend, Per Sonne Holm, Wolfgang Mikulits, Matthias Schwab, Lusine Danielyan, Ulrike Naumann
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system. Molecular oncology (2023)
Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Irene Gonzalez-Menendez, Leticia Quintanilla Fend, Per Sonne Holm, Wolfgang Mikulits, Matthias Schwab, Lusine Danielyan, Ulrike Naumann
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system. Molecular oncology 18 (3) (2023)
Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Irene Gonzalez-Menendez, Leticia Quintanilla Fend, Per Sonne Holm, Wolfgang Mikulits, Matthias Schwab, Lusine Danielyan, Ulrike Naumann
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system. Molecular oncology 18 (3) (2023)
Ali El-Ayoubi, Moritz Klawitter, Jakob Rüttinger, Giulia Wellhäusser, Per Sonne Holm, Lusine Danielyan, Ulrike Naumann
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice. Cancers 15 (20) (2023)
Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Irene Gonzalez-Menendez, Leticia Quintanilla Fend, Per Sonne Holm, Wolfgang Mikulits, Matthias Schwab, Lusine Danielyan, Ulrike Naumann
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system. Molecular oncology 18 (3) (2023)
Leonie Schumacher, Rédouane Slimani, Laimdota Zizmare, Jakob Ehlers, Felix Kleine Borgmann, Julia C Fitzgerald, Petra Fallier-Becker, Anja Beckmann, Alexander Grißmer, Carola Meier, Ali El-Ayoubi, Kavi Devraj, Michel Mittelbronn, Christoph Trautwein, Ulrike Naumann
TGF-Beta Modulates the Integrity of the Blood Brain Barrier In Vitro, and Is Associated with Metabolic Alterations in Pericytes. Biomedicines 11 (1) (2023)
Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Irene Gonzalez-Menendez, Leticia Quintanilla-Fend, Per Sonne Holm, Wolfgang Mikulits, Matthias Schwab, Lusine Danielyan, Ulrike Naumann
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system. Molecular oncology (2023)
Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Irene Gonzalez-Menendez, Leticia Quintanilla Fend, Per Sonne Holm, Wolfgang Mikulits, Matthias Schwab, Lusine Danielyan, Ulrike Naumann
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system. Molecular oncology 18 (3) (2023)
Moritz Klawitter, Ali El-Ayoubi, Jasmin Buch, Jakob Rüttinger, Maximilian Ehrenfeld, Eva Lichtenegger, Marcel A Krüger, Klaus Mantwill, Florestan J Koll, Markus C Kowarik, Per Sonne Holm, Ulrike Naumann
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model. International journal of molecular sciences 23 (17) (2022)
Nicolai Stransky, Katrin Ganser, Ulrike Naumann, Stephan M Huber, Peter Ruth
Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of K Ca 3.1 K + Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction. Cancers 14 (24) (2022)
Nicolai Stransky, Katrin Ganser, Ulrike Naumann, Stephan M Huber, Peter Ruth
Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of K Ca 3.1 K + Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction. Cancers 14 (24) (2022)
Dirk M Nettelbeck, Mathias F Leber, Jennifer Altomonte, Assia L Angelova, Julia Beil, Susanne Berchtold, Maike Delic, Jürgen Eberle, Anja Ehrhardt, Christine E Engeland, Henry Fechner, Karsten Geletneky, Katrin Goepfert, Per Sonne Holm, Stefan Kochanek, Florian Kreppel, Lea Krutzke, Florian Kühnel, Karl Sebastian Lang, Antonio Marchini, Markus Möhler, Michael D Mühlebach, Ulrike Naumann, Roman Nawroth, Jürg P F Nüesch, Jean Rommelaere, Ulrich M Lauer, Guy Ungerechts
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies. Viruses 13 (8) (2021)
Naita M Wirsik, Jakob Ehlers, Lisa Mäder, Elena I Ilina, Anna-Eva Blank, Anne Grote, Friedrich Feuerhake, Peter Baumgarten, Kavi Devraj, Patrick N Harter, Michel Mittelbronn, Ulrike Naumann
TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma. Neuropathology and applied neurobiology 47 (6) (2021)
Nikhil Ranjan, Vimal Pandey, Manas Kumar Panigrahi, Lukas Klumpp, Ulrike Naumann, Phanithi Prakash Babu
The Tumor Suppressor MTUS1/ATIP1 Modulates Tumor Promotion in Glioma: Association with Epigenetics and DNA Repair. Cancers 13 (6) (2021)
Sonja Schötterl, Jennifer T Miemietz, Elena I Ilina, Naita M Wirsik, Ingrid Ehrlich, Andrea Gall, Stephan M Huber, Hans Lentzen, Michel Mittelbronn, Ulrike Naumann
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Sonja Schötterl, Stephan M Huber, Hans Lentzen, Michel Mittelbronn, Ulrike Naumann
Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)